HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Evenden Selected Research

4,2'- difluoro- 5'- (8- fluoro- 7- (1- hydroxy- 1- methylethyl)imidazo(1,2- a)pyridin- 3- yl)biphenyl- 2- carbonitrile

5/2009A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Evenden Research Topics

Disease

1Cognitive Dysfunction
10/2013
1Neoplasms (Cancer)
10/2013
1Shock
05/2009

Drug/Important Bio-Agent (IBA)

1Biological ProductsIBA
10/2013
1Chlordiazepoxide (Elenium)FDA LinkGeneric
05/2009
1Anti-Anxiety Agents (Anxiolytics)IBA
05/2009
1gamma-Aminobutyric Acid (GABA)IBA
05/2009
17- (1,1- dimethylethyl)- 6- (2- ethyl- 2H- 1,2,4- triazol- 3- ylmethoxy)- 3- (2- fluorophenyl)- 1,2,4- triazolo(4,3- b)pyridazineIBA
05/2009
14,2'- difluoro- 5'- (8- fluoro- 7- (1- hydroxy- 1- methylethyl)imidazo(1,2- a)pyridin- 3- yl)biphenyl- 2- carbonitrileIBA
05/2009
1BenzodiazepinesIBA
05/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2013